Lymphoma Clinical Trials in Houston

Showing 381-400 of 533 trials

Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma

NCT02392039

The goal of this clinical research study is to learn if loratadine can control bone pain caused by pegfilgrastim (a drug given after chemotherapy to help raise white blood cell counts).

Lymphoma

M.D. Anderson Cancer Center1 participantsStarted Dec 2015

Houston, Texas, United States

COMPLETED< 1 mile

Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma

NCT00900250

This laboratory study is collecting and storing samples of tissue and blood from young patients with Hodgkin's lymphoma. Collecting and storing samples of tumor tissue and blood from patients with cancer to study in the laboratory may help the study of cancer in the future.

Ann Arbor Stage I Childhood Hodgkin LymphomaAnn Arbor Stage II Childhood Hodgkin LymphomaAnn Arbor Stage III Childhood Hodgkin Lymphoma+2 more

Children's Oncology Group1,271 participantsStarted Oct 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +180 more locations

Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma

Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma

Lymphoma Trials in Other Cities

Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma

The Safety, Pharmacokinetic and Pharmacodynamic Effect of KA2237 (PI3 Kinase p110β/δ Inhibitor) In B Cell Lymphoma

Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas

Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma

Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma

A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL

Pharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Function

Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach

Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma

Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas

A Study of Enzastaurin in Participants With Follicular Lymphoma

A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial

A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas

Other Conditions in Houston